Background/Objectives: Alzheimer’s disease (AD) is marked by amyloid-β plaques and hyperphosphorylated tau neurofibrillary tangles (NFTs), leading to cognitive decline and debilitating non-cognitive symptoms. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.